Friday, November 26, 2021 9:30:22 AM
Did blowing past the PFS trigger serve to create certainty or uncertainty?
Did continuing on past 233 deaths serve to create certainty or uncertainty?
Did extending time between preparing to lock the data in Nov 2018 to actually locking the database in Oct 2020 serve to create certainty or uncertainty?
Does testing for IDH mutation in the database serve to create certainty or uncertainty?
Did LL foreshadowing data analysis, likely outcome, and future research directions for GBM serve to create certainty or uncertainty?
Does advertising your product (technology or vaccine based upon your beliefs) serve to create certainty or uncertainty?
It is up to you whether or not you are certain of your investment thesis.
I know two things for certain. First, the only rationale explanation ever offered regarding the Halt in use of Placebo during the screening and randomization phase of the trial is that the DSM saw a clinically meaningful difference in death rate between DCVax treated patients and placebo treated patients and called for a halt of the trial. LP refused the halt and the rest is history.
Second, FDA granted Northwest Biotherapeutics and Early Access Program which was employed for a period of time. EAPs are only given to promising therapies that have shown sufficient evidence of both safety and efficacy so as to deem them appropriate for broader use outside the trial. This EAP is still active. It was not taken away from them, although I am not sure why it has not been employed to offset the fees paid to Cognate. They already had sites up and running with it but then stopped. I have a theory which I may share at some time with you and it is consistent with most everything I have put out there. They never needed “Right to Try,” they had been given the right already. They could have restarted today if they wished to do so, except they can’t.
All the other stuff that causes angst and churn IMO was to create FOMO so that retail wouldn’t shoot itself in the foot and kill the plan. I just wish my wife would allow me to take advantage of this opportunity. But like TRYN2, I fear what could happen if I did.
And BTW, those early people who died after getting placebo, never had the opportunity to be forced on to therapy. So, you could never get to 100% treated, only >90%.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM